Similar articles

• Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline.

  Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Chou R, et al. J Pain. 2009 Feb;10(2):131-46. doi: 10.1016/j.jpain.2008.10.009. J Pain. 2009. PMID: 19187890 Review.
• Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain.

  Wasan AD, Butler SF, Budman SH, Benoit C, Fernandez K, Jamison RN. Wasan AD, et al. Clin J Pain. 2007 May;23(4):307-15. doi: 10.1097/AJP.0b013e3180330dc5. Clin J Pain. 2007. PMID: 17449991
• Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

  Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
• [Abuse of opioid therapy in somatoform pain disorder. A contribution from a psychosomatic/pain therapist point of view to the discussion of the indication of opioids in nonmalignant pain based on 8 cases].

  Wambach S, Rohr P, Häuser W. Wambach S, et al. Schmerz. 2001 Aug;15(4):254-64. Schmerz. 2001. PMID: 11810364 German.
• Opioid therapy for chronic painful conditions.

  Burgess FW. Burgess FW. Med Health R I. 2001 Oct;84(10):323-6. Med Health R I. 2001. PMID: 11693049 No abstract available.